S N Bykovskaia - JoVE Visualize

Showing results (31-40 of 37) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 37 results.

Biulleten' Eksperimental'Noi Biologii I Meditsiny|November 1, 1991

[A comparison of the suppressor and cytotoxic activities of the blood mononuclear cells during the adoptive immunotherapy of cancer patients using lymphokine-activated killers with a low dose of recombinant interleukin-2]I F Abronina, T A Kupriianova, A V Bolvachova, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|April 13, 2016

[The treatment by expanded ex vivo autologous regulatory T-cells CD4+CD25+FoxP3+CD127low restores the balance of immune system in patients with remitting-relapsing multiple sclerosis]D D Eliseeva, G V Lifshitz, A V Lokhonina, et al.

Biulleten' Eksperimental'Noi Biologii I Meditsiny|October 1, 1992

[The effect of recombinant interleukin-2 on the course of experimental staphylococcal peritonitis in mice]O V Shadrin, N A Khar'kovskaia, O Ia Kaufman, et al.

British Journal of Cancer|August 17, 2000

Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteinsG Pirtskhalaishvili, G V Shurin, C Esche, et al.

Journal of Leukocyte Biology|October 26, 1999

The generation of human dendritic and NK cells from hemopoietic progenitors induced by interleukin-15S N Bykovskaia, M Buffo, H Zhang, et al.

Science (New York, N.Y.)|October 16, 1999

Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6D Yang, O Chertov, S N Bykovskaia, et al.

Patologicheskaia Fiziologiia I Eksperimental'Naia Terapiia|March 1, 1990

[The preclinical assessment of the activity and pharmacological action of native human interleukin-2]N V Malakhova, I D Treshchalin, M S Iobadze, et al.

Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 37 results.

Biulleten' Eksperimental'Noi Biologii I Meditsiny|November 1, 1991

[A comparison of the suppressor and cytotoxic activities of the blood mononuclear cells during the adoptive immunotherapy of cancer patients using lymphokine-activated killers with a low dose of recombinant interleukin-2]I F Abronina, T A Kupriianova, A V Bolvachova, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|April 13, 2016

[The treatment by expanded ex vivo autologous regulatory T-cells CD4+CD25+FoxP3+CD127low restores the balance of immune system in patients with remitting-relapsing multiple sclerosis]D D Eliseeva, G V Lifshitz, A V Lokhonina, et al.

Biulleten' Eksperimental'Noi Biologii I Meditsiny|October 1, 1992

[The effect of recombinant interleukin-2 on the course of experimental staphylococcal peritonitis in mice]O V Shadrin, N A Khar'kovskaia, O Ia Kaufman, et al.

British Journal of Cancer|August 17, 2000

Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteinsG Pirtskhalaishvili, G V Shurin, C Esche, et al.

Journal of Leukocyte Biology|October 26, 1999

The generation of human dendritic and NK cells from hemopoietic progenitors induced by interleukin-15S N Bykovskaia, M Buffo, H Zhang, et al.

Science (New York, N.Y.)|October 16, 1999

Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6D Yang, O Chertov, S N Bykovskaia, et al.

Patologicheskaia Fiziologiia I Eksperimental'Naia Terapiia|March 1, 1990

[The preclinical assessment of the activity and pharmacological action of native human interleukin-2]N V Malakhova, I D Treshchalin, M S Iobadze, et al.

Pageof 4